肺ドラッグデリバリーデバイスの世界市場レポート 2025年

肺ドラッグデリバリーデバイス市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.1％で699億1,000万米ドルに成長します。予測期間の成長は、呼吸ケアにおける個別化医療や精密医療への需要の高まり、在宅医療サービスや遠隔患者モニタリングの拡大、研究開発投資の増加、予防医療や早期介入戦略への注目の高まりなどに起因すると考えられます。予測期間における主要動向としては、技術革新、価値によるケアモデルや患者中心のアプローチへの移行、遠隔医療や遠隔モニタリング機能の呼吸器治療プラットフォームへの統合、呼吸器疾患の自己管理のためのウェアラブルやモバイルアプリケーションの活用、3Dプリンティングやデジタル製造技術の採用などが挙げられます。

呼吸器疾患の有病率の増加は、今後の肺ドラッグデリバリーデバイス市場の成長を促進すると予想されます。呼吸器疾患は、肺や気道に影響を及ぼし、人間の呼吸を損なう疾患や状態です。呼吸器疾患の有病率の増加は、大気汚染レベルの上昇、喫煙率の増加、都市化、気候変動、高齢化などのいくつかの要因によるものです。肺ドラッグデリバリーデバイスは、肺への直接的な薬剤送達を可能にすることで、呼吸器疾患の治療に重要な役割を果たしています。例えば、2024年5月、米国を拠点とする国立公衆衛生機関である疾病対策予防センター（CDC）は、18歳以上の成人における現在の喘息の有病率が、2021年の8.0％から2022年には8.7％に増加したと報告しました。このように、呼吸器疾患の有病率の上昇は、肺ドラッグデリバリーデバイス市場の成長を促進すると予測されています。

肺ドラッグデリバリーデバイス市場の主要企業は、小容量ネブライザーなどの革新的な製品を開発し、先進的機能で顧客により良いサービスを提供しています。少量ネブライザー（SVN）は、喘息、慢性閉塞性肺疾患（COPD）、嚢胞性線維症などの呼吸器疾患の患者にエアロゾル化されたミストの形で液体薬剤を送達するために使用される医療機器です。例えば、2024年5月、米国の医療企業であるMedline Industries, LPは、ハドソンRCIターボミスト小容量ネブライザーを発売しました。この画期的な装置は、わずか3分という短時間で薬剤治療を行えるように設計されています。この革新的なネブライザーは、標準的なネブライザーと比較して、1分間に2.5倍の薬剤を吐出することができ、治療時間を約70％短縮することができます。この投薬量の増加は治療時間を大幅に短縮し、患者の処理能力を最適化することで医療プロバイダに利益をもたらし、治療セッションの時間を短縮することで患者の体験を向上させます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の肺ドラッグデリバリーデバイス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の肺ドラッグデリバリーデバイス市場：成長率分析
• 世界の肺ドラッグデリバリーデバイス市場の実績：規模と成長、2019～2024年
• 世界の肺ドラッグデリバリーデバイス市場の予測：規模と成長、2024～2029年、2034年
• 世界の肺ドラッグデリバリーデバイス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の肺ドラッグデリバリーデバイス市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ドライ粉末吸入器（DPI）
• 定量噴霧式吸入器（MDI）
• ネブライザー
• 世界の肺ドラッグデリバリーデバイス市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 喘息
• 嚢胞性線維症
• 慢性閉塞性肺疾患
• その他
• 世界の肺ドラッグデリバリーデバイス市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 小売薬局
• 病院薬局
• eコマース
• 世界の肺ドラッグデリバリーデバイス市場、ドライ粉末吸入器（DPI）のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 単回投与DPI
• 多回投与DPI
• 世界の肺ドラッグデリバリーデバイス市場、定量噴霧式吸入器（MDI）のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• CFCベースのMDI
• HFAベースのMDI
• 世界の肺ドラッグデリバリーデバイス市場、ネブライザーのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ジェットネブライザー
• 超音波ネブライザー
• メッシュネブライザー

第7章 地域別・国別分析

• 世界の肺ドラッグデリバリーデバイス市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の肺ドラッグデリバリーデバイス市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 肺ドラッグデリバリーデバイス市場：競合情勢
• 肺ドラッグデリバリーデバイス市場：企業プロファイル
  • Medtronic plc
  • Air Liquide S.A.
  • Becton Dickinson and Company
  • Koninklijke Philips N.V.
  • Medline Industries Inc.

第31章 その他の大手企業と革新的企業

• ResMed Inc.
• Dragerwerk AG And Co. KGaA
• Smiths Group plc
• AptarGroup Inc.
• Chiesi Farmaceutici S.p.A.
• Teleflex Incorporated
• Masimo Corporation
• Fisher And Paykel Healthcare Limited
• Invacare Corporation
• Vyaire Medical Inc.
• Inogen Inc.
• Drive DeVilbiss Healthcare Inc.
• Hovione
• Hamilton Medical AG
• GaleMed Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 肺ドラッグデリバリーデバイス市場、2029年：新たな機会を提供する国
• 肺ドラッグデリバリーデバイス市場、2029年：新たな機会を提供するセグメント
• 肺ドラッグデリバリーデバイス市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Pulmonary drug delivery devices are inhalation devices designed to administer medications directly to the lungs. These devices enable targeted drug delivery for treating respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Additionally, pulmonary delivery allows for the systemic absorption of drugs such as insulin and pain medications.

The primary types of pulmonary drug delivery devices include dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers dispense a measured dose of medication in a fine, dry powder form that the patient inhales directly into their lungs. These devices are used for conditions such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and others. They are distributed through channels such as retail pharmacies, hospital pharmacies, and e-commerce.

The pulmonary drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides pulmonary drug delivery devices market statistics, including the pulmonary drug delivery devices industry global market size, regional shares, competitors with pulmonary drug delivery devices market share, detailed pulmonary drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the pulmonary drug delivery devices industry. These pulmonary drug delivery devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pulmonary drug delivery devices market size has grown strongly in recent years. It will grow from $49.52 billion in 2024 to $53.21 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, the growing aging population worldwide, rising awareness about the importance of respiratory health, expansion of healthcare expenditure in emerging economies, and increasing adoption of homecare settings for respiratory therapy.

The pulmonary drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $69.91 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to the growing demand for personalized and precision medicine in respiratory care, expansion of home healthcare services and remote patient monitoring, rising investments in research and development, and increasing focus on preventive healthcare and early intervention strategies. Major trends in the forecast period include technological innovations, the shift towards value-based care models and patient-centric approaches, the integration of telehealth and remote monitoring capabilities into respiratory therapy platforms, the utilization of wearables and mobile applications for self-management of respiratory conditions, and the adoption of 3D printing and digital manufacturing techniques.

The growing prevalence of respiratory disorders is expected to drive the growth of the pulmonary drug delivery devices market in the future. Respiratory disorders are diseases or conditions that affect the lungs and airways, impairing human respiration. The increasing prevalence of respiratory disorders is due to several factors, such as rising levels of air pollution, increased smoking rates, urbanization, climate change, and an aging population. Pulmonary drug delivery devices play a crucial role in treating respiratory disorders by enabling direct medication delivery to the lungs. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported that the prevalence of current asthma among adults aged 18 and over increased from 8.0% in 2021 to 8.7% in 2022. Thus, the rising prevalence of respiratory disorders is expected to drive the growth of the pulmonary drug delivery devices market.

Major companies in the pulmonary drug delivery devices market are developing innovative products, such as small-volume nebulizers, to better serve customers with advanced features. A small-volume nebulizer (SVN) is a medical device used to deliver liquid medication in the form of an aerosolized mist to patients with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. For instance, in May 2024, Medline Industries, LP, a US-based healthcare company, launched the Hudson RCI TurboMist small-volume nebulizer. This groundbreaking device is designed to deliver medication treatments quickly, in as little as three minutes. The innovative nebulizer can dispense 2.5 times more medication per minute compared to standard nebulizers, reducing treatment times by about 70%. This increase in medication delivery significantly reduces treatment times, benefiting healthcare providers by optimizing patient throughput and enhancing the patient experience by shortening the duration of therapy sessions.

In August 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. Through this acquisition, Sandoz aims to strengthen its portfolio of respiratory medicines and improve patient access to high-quality, complex therapies. Coalesce Product Development Limited is a UK-based company that provides pulmonary drug delivery devices.

Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Dragerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.

North America was the largest region in the pulmonary drug delivery devices market in 2024. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pulmonary drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pulmonary drug delivery devices market consists of sales of jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pulmonary Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pulmonary drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pulmonary drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pulmonary drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
• 2) By Application: Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Other Applications
• 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; E-Commerce
• Subsegments:
• 1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs; Multi-Dose DPIs
• 2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs; HFA-Based MDIs
• 3) By Nebulizers: Jet Nebulizers; Ultrasonic Nebulizers; Mesh Nebulizers
• Companies Mentioned: Medtronic plc; Air Liquide S.A.; Becton Dickinson and Company; Koninklijke Philips N.V.; Medline Industries Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pulmonary Drug Delivery Devices Market Characteristics

3. Pulmonary Drug Delivery Devices Market Trends And Strategies

4. Pulmonary Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pulmonary Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pulmonary Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pulmonary Drug Delivery Devices Market Growth Rate Analysis
• 5.4. Global Pulmonary Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pulmonary Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pulmonary Drug Delivery Devices Total Addressable Market (TAM)

6. Pulmonary Drug Delivery Devices Market Segmentation

• 6.1. Global Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dry Powder Inhalers
• Metered Dose Inhalers
• Nebulizers
• 6.2. Global Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Asthma
• Cystic Fibrosis
• Chronic Obstructive Pulmonary Disease
• Other Applications
• 6.3. Global Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail Pharmacies
• Hospital Pharmacies
• E-Commerce
• 6.4. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Dry Powder Inhalers (DPIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose DPIs
• Multi-Dose DPIs
• 6.5. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Metered Dose Inhalers (MDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CFC-Based MDIs
• HFA-Based MDIs
• 6.6. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Jet Nebulizers
• Ultrasonic Nebulizers
• Mesh Nebulizers

7. Pulmonary Drug Delivery Devices Market Regional And Country Analysis

• 7.1. Global Pulmonary Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pulmonary Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pulmonary Drug Delivery Devices Market

• 8.1. Asia-Pacific Pulmonary Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pulmonary Drug Delivery Devices Market

• 9.1. China Pulmonary Drug Delivery Devices Market Overview
• 9.2. China Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pulmonary Drug Delivery Devices Market

• 10.1. India Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pulmonary Drug Delivery Devices Market

• 11.1. Japan Pulmonary Drug Delivery Devices Market Overview
• 11.2. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pulmonary Drug Delivery Devices Market

• 12.1. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pulmonary Drug Delivery Devices Market

• 13.1. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pulmonary Drug Delivery Devices Market

• 14.1. South Korea Pulmonary Drug Delivery Devices Market Overview
• 14.2. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pulmonary Drug Delivery Devices Market

• 15.1. Western Europe Pulmonary Drug Delivery Devices Market Overview
• 15.2. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pulmonary Drug Delivery Devices Market

• 16.1. UK Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pulmonary Drug Delivery Devices Market

• 17.1. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pulmonary Drug Delivery Devices Market

• 18.1. France Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pulmonary Drug Delivery Devices Market

• 19.1. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pulmonary Drug Delivery Devices Market

• 20.1. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pulmonary Drug Delivery Devices Market

• 21.1. Eastern Europe Pulmonary Drug Delivery Devices Market Overview
• 21.2. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pulmonary Drug Delivery Devices Market

• 22.1. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pulmonary Drug Delivery Devices Market

• 23.1. North America Pulmonary Drug Delivery Devices Market Overview
• 23.2. North America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pulmonary Drug Delivery Devices Market

• 24.1. USA Pulmonary Drug Delivery Devices Market Overview
• 24.2. USA Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pulmonary Drug Delivery Devices Market

• 25.1. Canada Pulmonary Drug Delivery Devices Market Overview
• 25.2. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pulmonary Drug Delivery Devices Market

• 26.1. South America Pulmonary Drug Delivery Devices Market Overview
• 26.2. South America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pulmonary Drug Delivery Devices Market

• 27.1. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pulmonary Drug Delivery Devices Market

• 28.1. Middle East Pulmonary Drug Delivery Devices Market Overview
• 28.2. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pulmonary Drug Delivery Devices Market

• 29.1. Africa Pulmonary Drug Delivery Devices Market Overview
• 29.2. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pulmonary Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Pulmonary Drug Delivery Devices Market Competitive Landscape
• 30.2. Pulmonary Drug Delivery Devices Market Company Profiles
  • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Air Liquide S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pulmonary Drug Delivery Devices Market Other Major And Innovative Companies

• 31.1. ResMed Inc.
• 31.2. Dragerwerk AG And Co. KGaA
• 31.3. Smiths Group plc
• 31.4. AptarGroup Inc.
• 31.5. Chiesi Farmaceutici S.p.A.
• 31.6. Teleflex Incorporated
• 31.7. Masimo Corporation
• 31.8. Fisher And Paykel Healthcare Limited
• 31.9. Invacare Corporation
• 31.10. Vyaire Medical Inc.
• 31.11. Inogen Inc.
• 31.12. Drive DeVilbiss Healthcare Inc.
• 31.13. Hovione
• 31.14. Hamilton Medical AG
• 31.15. GaleMed Corporation

32. Global Pulmonary Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pulmonary Drug Delivery Devices Market

34. Recent Developments In The Pulmonary Drug Delivery Devices Market

35. Pulmonary Drug Delivery Devices Market High Potential Countries, Segments and Strategies

• 35.1 Pulmonary Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pulmonary Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pulmonary Drug Delivery Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer